LTTL vs Telos Rx: Pricing, Meds, and Pharmacy Differences
LTTL vs Telos Rx quickly compared: LTTL emphasizes compounded full-dose GLP-1 prepared by U.S. licensed pharmacies with lab verification and an offer of up to $140 off your first month, while Telos Rx lists compounded semaglutide as low as $99 per month and tirzepatide as low as $139 per month subject to approval by a US-licensed provider. Early verdict: choose LTTL if you prioritize pharmacy verification and full-dose GLP-1 compounded by U.S. licensed pharmacies; choose Telos Rx if you need lower starting prices or a choice between semaglutide and tirzepatide.
Visit LTTL for full-dose GLP-1 options
Key differences at a glance
The comparison centers on four distinctive differences: starting price and discounts, available molecules, pharmacy and lab handling, and regulatory notes about compounded medications. Both providers require clinician review and make compounded medications available, with specific pricing and preparation differences below.
1. Pricing and introductory offers
LTTL lists pricing details that include specific amounts and a promotion: up to $140 off your first month with a code auto-applied and noted prices such as $249 and $129 for certain dose packs. Telos Rx lists per month starting points: semaglutide as low as $99 per month and tirzepatide as low as $139 per month, and states you may pay $0 if not approved. Telos Rx also says prices like $299 and $399 with lower as low as amounts. Both emphasize that pricing and eligibility are subject to the live offer and clinician approval.
See Telos Rx pricing and molecule options
2. Medication options and clinical matching
LTTL promotes a powerful, full-dose GLP-1 weight loss medication compounded and delivered, framed as a single full-dose GLP-1 offering. Telos Rx offers two molecules: semaglutide, which acts on GLP-1, and tirzepatide, which acts on GLP-1 and GIP. Telos Rx states a US-licensed provider decides which molecule is right for you.
3. Pharmacy preparation and lab verification
LTTL specifies that compounded medications are prepared by U.S.A. licensed pharmacies, independently verified in FDA registered labs, and confirmed every 3 to 6 months to stay within plus or minus 10 percent of the target strength. Telos Rx indicates semaglutide and tirzepatide are compounded medications and prescription-only, prescribed after review by a US-licensed provider, but does not provide the same lab verification language in the captured evidence.
4. Regulatory and clinician review notes
Both providers state treatment is available only when a licensed clinician determines it is medically appropriate. Both include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Telos Rx additionally notes individual results vary and are not guaranteed. LTTL repeats the compounded medication regulatory note in the captured evidence.
Side-by-side comparison table
| Criteria | LTTL | Telos Rx |
|---|---|---|
| Starting price / offers | Up to $140 off your first month; listed prices include $249 and $129 | Semaglutide as low as $99 per month; tirzepatide as low as $139 per month |
| Available molecules | Full-dose GLP-1 (compounded) | Semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) |
| Pharmacy and lab handling | Compounded by U.S.A. licensed pharmacies; independently verified in FDA registered labs; confirmed every 3-6 months within ± 10% strength | Compounded and prescribed after review by a US-licensed provider; pharmacy verification details not captured |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
| Clinician approval | Treatment available only when a licensed clinician determines it is medically appropriate | Treatment available only when a licensed clinician determines it is medically appropriate; medical approval by a US-licensed provider required |
How these differences affect choice
If cost sensitivity and molecule choice matter, Telos Rx explicitly lists lower as low as monthly prices for semaglutide and a dual-action option in tirzepatide, subject to provider approval. If verified pharmacy compounding, lab testing and a stated full-dose GLP-1 offering are priorities, LTTL documents U.S. licensed pharmacy preparation and lab verification with periodic strength confirmation.
Check LTTL preparation and verification details
Final comparison and recommendation
Both providers require clinician review and offer compounded GLP-1 options with regulatory cautions. LTTL vs Telos Rx differs most on price promotion and molecule variety, plus LTTL includes captured lab verification language. Use the primary keyword here: LTTL vs Telos Rx when deciding which set of tradeoffs fits your priorities.
Choose LTTL to review full-dose GLP-1 and lab verification
Choose LTTL if…
- You prioritize compounded medications prepared by U.S.A. licensed pharmacies and independent FDA registered lab verification with periodic strength confirmation.
- You are considering a full-dose GLP-1 offering and want the documented lab handling and confirmation in the captured evidence.
Choose Telos Rx if…
- You want lower starting monthly pricing listed for semaglutide as low as $99 per month or tirzepatide as low as $139 per month, and the option to be matched to semaglutide or tirzepatide by a US-licensed provider.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →